Virulina: Patent-Awarded Polyherbal Breakthrough for Viral Respiratory Infection and Immunomodulatory Conditions

New Delhi [India], September 22: Viral respiratory infections (VRIs) have long been a persistent challenge for global healthcare. From seasonal flu-like illnesses to more severe viral conditions, these infections often affect millions each year, causing breathlessness, persistent cough, fatigue, and in many cases, long-term respiratory damage. Despite advances in modern medicine, treatment options remain limited, with many patients relying only on symptomatic relief. Unfortunately, overuse of antibiotics—despite their ineffectiveness…